MESO-Rx
Anabolic Steroids
The Lobster International, AU, CANADA and EU Domestic HGH, PEPTIDES and Turkish Pharmacy
- Thread starter TheLobster
- Start date
I think the math is off a little bit. If you get 2.75 IU out of each gram of HGH someone is getting over on you x1000
TheLobster
Subscriber
My friend
There is nothing wrong with the math.
We also sell HGH raw materials, and each gram of HGH raw material contains 2,750 IU
Not 2.75
bighunanballs
Member
wouldnt 1000mg at say 98% purity be 980mg X 3 = 2940iu?
TheLobster
Subscriber
No. Its exactly how i write. 2,750 iu around.
bighunanballs
Member
so 1000mg of rHGH raw weighs 916.66mg? 2750/3
TheLobster
Subscriber
My friend
Please do not perform mathematical calculations. Raw materials are experiencing losses during the production stage. As I told you, it is 2,750 IU. I hope I have made myself clear
For example, in 1 gram of BPC raw material, you cannot have 100 vials x 10 mg of product. You can only have up to 88-85 vials x 10 mg of product. There are always losses during the raw material production process.
What you’re thinking is that 1 gram equals 1,000 mg, so you believe you can have 100 vials x 10 mg of product. However, this doesn’t happen during the production stage. I hope you understand now
Thank you
Last edited:
Very interesting. Thanks for sharing. So that's roughly 8 to 9% yield loss over your production and finishing process.
Also I read glycine is also part of that recipe above? Could you disclose that mass as well in the recipe?
Very nice.
TheLobster
Subscriber
It depends on the raw material. Some raw materials can have losses up to 20%, while others may only lose about 4-5
Thank you
Somatropin production process 1.0 and 1.1 (Genentech) for those interested. Gives one an appreciation for production and purification steps....
Supplement
From:
pmc.ncbi.nlm.nih.gov
Supplement
From:
Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product - PMC
Manufacturing process changes may alter the characteristics of a protein therapeutic. In 2009, somatropin (version 1.0), a recombinant human growth hormone therapeutic, underwent a manufacturing update (version 1.1). The immunogenicity of somatropin ...
pmc.ncbi.nlm.nih.gov
My comment was regarding the GH numbers you shared. Understood on your other peptides.
In that original post he was writing Euro convention. Period instead of comma.
2.750 euro is 2,750 US
Ghoul
Member
Somatropin production process 1.0 and 1.1 (Genentech) for those interested. Gives one an appreciation for production and purification steps....
Supplement
From:
Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product - PMC
Manufacturing process changes may alter the characteristics of a protein therapeutic. In 2009, somatropin (version 1.0), a recombinant human growth hormone therapeutic, underwent a manufacturing update (version 1.1). The immunogenicity of somatropin ...
What is this "immunogenicity" they go on and on about? 30+ references. They seem awfully sensitive about it, and imply even the smallest changes to production or formulation could cause it to become a problem.
Ghoul
Member
Stupid fuckers. Alarmists.
Bubble boy and girl clowns.
If these biochemists and pharmaceutical engineers would just spend a few days at one of the UGLs that supply us, they could learn the secrets to making immunogenic free peptides and save themselves a lot of effort.
AlexDavis43
Member
hahaha sick burn
You got the math right. Just terminology...process purification yield loss. ~9% based on numbers shared.
Too bad many are interested in "sick burns" rather than focusing on opportunity to educate.
I am now enlightened!
Similar threads
